cisatracurium besylate
Generic: cisatracurium besylate
Labeler: meitheal pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
cisatracurium besylate
Generic Name
cisatracurium besylate
Labeler
meitheal pharmaceuticals inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
cisatracurium besylate 200 mg/20mL
Manufacturer
Identifiers & Regulatory
Product NDC
71288-713
Product ID
71288-713_c603acf5-af33-479a-8986-fbceb96ff1e5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211668
Listing Expiration
2026-12-31
Marketing Start
2019-10-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71288713
Hyphenated Format
71288-713
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cisatracurium besylate (source: ndc)
Generic Name
cisatracurium besylate (source: ndc)
Application Number
ANDA211668 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/20mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-95)
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c603acf5-af33-479a-8986-fbceb96ff1e5", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199211", "199212", "1730194"], "spl_set_id": ["1be30efe-4beb-411a-bf82-6e4ea68fd262"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-95)", "package_ndc": "71288-713-96", "marketing_start_date": "20191031"}], "brand_name": "Cisatracurium Besylate", "product_id": "71288-713_c603acf5-af33-479a-8986-fbceb96ff1e5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "71288-713", "generic_name": "Cisatracurium Besylate", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "200 mg/20mL"}], "application_number": "ANDA211668", "marketing_category": "ANDA", "marketing_start_date": "20191031", "listing_expiration_date": "20261231"}